Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Anti-fungal activity of a novel triazole, PC1244, against emerging azole-resistant Aspergillus fumigatus and other species of Aspergillus.

Colley T, Sharma C, Alanio A, Kimura G, Daly L, Nakaoki T, Nishimoto Y, Bretagne S, Kizawa Y, Strong P, Rapeport G, Ito K, Meis JF, Chowdhary A.

J Antimicrob Chemother. 2019 Oct 1;74(10):2950-2958. doi: 10.1093/jac/dkz302.

2.

Antifungal synergy of a topical triazole, PC945, with a systemic triazole against respiratory Aspergillus fumigatus infection.

Colley T, Sehra G, Daly L, Kimura G, Nakaoki T, Nishimoto Y, Kizawa Y, Strong P, Rapeport G, Ito K.

Sci Rep. 2019 Jul 1;9(1):9482. doi: 10.1038/s41598-019-45890-w.

3.

Effects of intranasally dosed posaconazole on fungal load and biomarkers in Aspergillus fumigatus infected immunocompromised mice.

Kimura G, Nakaoki T, Nishimoto Y, Suzuki Y, Rapeport G, Strong P, Ito K, Kizawa Y.

Mycoses. 2017 Nov;60(11):728-735. doi: 10.1111/myc.12653. Epub 2017 Jul 11.

PMID:
28699245
4.

In Vivo Biomarker Analysis of the Effects of Intranasally Dosed PC945, a Novel Antifungal Triazole, on Aspergillus fumigatus Infection in Immunocompromised Mice.

Kimura G, Nakaoki T, Colley T, Rapeport G, Strong P, Ito K, Kizawa Y.

Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e00124-17. doi: 10.1128/AAC.00124-17. Print 2017 Sep.

5.

In Vitro and In Vivo Antifungal Profile of a Novel and Long-Acting Inhaled Azole, PC945, on Aspergillus fumigatus Infection.

Colley T, Alanio A, Kelly SL, Sehra G, Kizawa Y, Warrilow AGS, Parker JE, Kelly DE, Kimura G, Anderson-Dring L, Nakaoki T, Sunose M, Onions S, Crepin D, Lagasse F, Crittall M, Shannon J, Cooke M, Bretagne S, King-Underwood J, Murray J, Ito K, Strong P, Rapeport G.

Antimicrob Agents Chemother. 2017 Apr 24;61(5). pii: e02280-16. doi: 10.1128/AAC.02280-16. Print 2017 May.

6.

Label-Free Separation of Induced Pluripotent Stem Cells with Anti-SSEA-1 Antibody Immobilized Microfluidic Channel.

Otaka A, Kitagawa K, Nakaoki T, Hirata M, Fukazawa K, Ishihara K, Mahara A, Yamaoka T.

Langmuir. 2017 Feb 14;33(6):1576-1582. doi: 10.1021/acs.langmuir.6b04070. Epub 2017 Jan 31.

PMID:
28092949
7.

Individual evaluation of cardiac marker expression and self-beating during cardiac differentiation of P19CL6 cells on different culture substrates.

Yamaoka T, Hirata M, Dan T, Yamashita A, Otaka A, Nakaoki T, Miskon A, Kakinoki S, Mahara A.

J Biomed Mater Res A. 2017 Apr;105(4):1166-1174. doi: 10.1002/jbm.a.35977. Epub 2017 Feb 11.

PMID:
27977899
8.

[Studies on unutilized resources. V. The components of the flavonoids in Chenopodium genus plants. 1. Flavonoids of Chenopodium ambrosioides L].

Arisawa M, Minabe N, Saeki R, Takakuwa T, Nakaoki T.

Yakugaku Zasshi. 1971 May;91(5):522-4. Japanese. No abstract available.

PMID:
5105136
9.

[Studies on unutilized resources. II. A new flavonoid-glycoside in the leaves of Sorbaria stellipila Schneid (Rosaceae)].

Arisawa M, Nakaoki T.

Yakugaku Zasshi. 1969 May;89(5):705-6. Japanese. No abstract available.

PMID:
5818007
10.

[Studies on unutilized resources. I. A new glycoside in the fruit of Ophiopogon japonicus Ker-Gawler var. genuinus Maxim].

Arisawa M, Nakaoki T.

Yakugaku Zasshi. 1969 Jan;89(1):127-8. Japanese. No abstract available.

PMID:
5816974
11.

[Studies on the medicinal resources. XX. Component of the leaves of Plantago asiatica L].

NAKAOKI T, MORITA N, ASAKI M.

Yakugaku Zasshi. 1961 Dec;81:1697-9. Japanese. No abstract available.

PMID:
14478213

Supplemental Content

Loading ...
Support Center